News Releases

NYSE Lists 5 New HealthSharesTM ETFs
-Organized Vertically By Therapeutic Categories Tracking Healthcare, Life Science and Biotechnology-

New York, Jan. 23, 2007–NYSE Group, Inc. (NYSE: NYX) today announced that the first 5 HealthShares™ ETFs, created by XShares Advisors LLC, began trading on the New York Stock Exchange.   The initial 5 HealthShares™ ETFs are the first in a series of “verticals” representing specific areas of the healthcare sector, including life science, biotechnology and patient care. HealthShares™ family of funds tracks groups of large, mid and small cap companies concentrating on treatment innovations in cancer, infectious diseases and cardiology, among others.

“The Exchange is very proud to add the truly innovative family of HealthShares funds to our primary list of ETFs,” said NYSE Group, Inc. CEO, John A. Thain.   “As our first XShares listings, HealthShares mark the beginning of a strong partnership bringing some of the most uniquely conceived and designed funds to our markets, where we consistently set the industry standard in market quality.”

“These products represent a real breakthrough in fundamental design by offering investors the opportunity to discover and invest in baskets of stocks focused on pioneering the diagnosis, treatment and cure of many of the most well-known and debilitating diseases of our time,” said XShares Group Chairman and CEO, Bill Kridel.   “We are pleased to list these products on the NYSE and we look forward to introducing more product offerings in the future.”

Including today’s original listings, NYSE Group has 148 primary ETF listings and trades all other eligible ETFs on a UTP basis.   In 2006, NYSE Group handled over 43% of all ETF shares traded in the U.S. market.    As the largest exchange for ETF trading, NYSE Group is committed to offering investors the most innovative new investment options with superior pricing and market quality.

Fund Name


HealthShares™ Cardio Devices ETF


HealthShares™ Diagnostics ETF


HealthShares™ Emerging Cancer ETF


HealthShares™ Enabling Technologies ETF


HealthShares™ Patient Care Services ETF


  • The HealthShares™ Exchange Traded Funds includes a family of funds in addition to the 5 funds that are launching today. Additional funds are expected to be brought to market in the near future.

For more information and data on NYSE Group listed ETFs and other products, please visit:

About HealthShares
XShares Advisors LLC, a financial services company based in New York , is the creator of the HealthSharesä family of Exchange Traded Funds (ETFs). HealthSharesäETFs are organized into therapeutic ‘Verticals’ and represent specific areas of the healthcare, life science and biotechnology industries.  Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company’s website at:

About NYSE Group, Inc
NYSE Group, Inc. (NYSE:NYX) operates two securities exchanges: the New York Stock Exchange LLC (the “NYSE”) and NYSE Arca, Inc. (formerly known as the Pacific Exchange). NYSE Group is a leading provider of securities listing, trading and market data products and services. In 2006, on an average trading day, 2.3 billion shares, valued at $86.8 billion, were traded on the exchanges of the NYSE Group.

The NYSE is the world’s largest and most liquid cash equities exchange. The NYSE provides a reliable, orderly, liquid and efficient marketplace where investors buy and sell listed companies’ common stock and other securities.  On December 31, 2006 , the operating companies listed on the NYSE represented a total global market capitalization of $25.0 trillion.

NYSE Arca, Inc. operates the former ArcaEx®, the first open, all-electronic stock exchange in the United States , which has a leading position in trading exchange-traded funds and exchange-listed securities. NYSE Arca, Inc. is also an exchange for trading equity options.  NYSE Arca, Inc.’s trading platforms provide customers with fast electronic execution and open, direct and anonymous market access.

NYSE Regulation, an independent not-for-profit subsidiary, regulates member organizations through the enforcement of marketplace rules and federal securities laws. NYSE Regulation also ensures that companies listed on the NYSE and NYSE Arca meet their financial and corporate governance listing standards.

For more information on NYSE Group, go to:

Cautionary Note Regarding Forward-Looking Statements
Certain statements in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on NYSE Group’s current expectations and involve risks and uncertainties that could cause NYSE Group’s actual results to differ materially from those set forth in the statements. There can be no assurance that such expectations will prove to be correct. Actual results may differ materially from those expressed or implied in the forward-looking statements. Factors that could cause NYSE Group’s results to differ materially from current expectations include, but are not limited to:  NYSE Group’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Group’s Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Group that the projections will prove to be correct. NYSE Group undertakes no obligation to release any revisions to any forward-looking statements.

Contact: Eric Ryan
Phone: 212.656.2411